摘要
一篇综述——理解和推荐有着慢性氧化应激特点的现行疾病治疗和使用臭氧治疗两种方案的结合当前可读,臭氧绝对有毒这种观点是错误的,因为实验仅仅在肺或者人造的研究环境中进行着,而并没有与人体构造中真正的抗氧化能力相呼应,事实上,臭氧不仅有着潜在的毒理性,它也可以激发十分重要的生理反应,就如同很有治疗前景价值的气体:NO, CO, H2S, H2以及O2 本身,这样一个关键的区别在过去十年中越来越明显。这篇综述的目的就是为了解释依旧很难被理解的方面,强调在不同的生理区域,臭氧的多样性。它将澄清并不只依赖于最后的气体浓度,而且与特定的生物系统有关这样的一个双重效应,臭氧作为辅助治疗的真正意义涉及了严重的慢性疾病包括心血管疾病、慢性阻塞性肺疾病、多发性硬化、干燥形式的年龄相关性黄斑变性等。现在是时候在医药科学界完全插入臭氧疗法以应对质量,有效性和安全性的全部要求,而不只是一种可供选择的或者深奥的方法了。
关键词: 臭氧,氧化剂,氧化应激、抗氧化剂、毒物兴奋效应
Current Medicinal Chemistry
Title:Ozone: A Multifaceted Molecule with Unexpected Therapeutic Activity
Volume: 23 Issue: 4
Author(s): I. Zanardi, E. Borrelli, G. Valacchi, V. Travagli and V. Bocci
Affiliation:
关键词: 臭氧,氧化剂,氧化应激、抗氧化剂、毒物兴奋效应
摘要: A comprehensive outline for understanding and recommending the therapeutic use of ozone in combination with established therapy in diseases characterized by a chronic oxidative stress is currently available. The view of the absolute ozone toxicity is incorrect, because it has been based either on lung or on studies performed in artificial environments that do not correspond to the real antioxidant capacity of body compartments. In fact, ozone exerts either a potent toxic activity or it can stimulate biological responses of vital importance, analogously to gases with prospective therapeutic value such as NO, CO, H2S, H2, as well as O2 itself. Such a crucial difference has increasingly become evident during the last decade. The purpose of this review is to explain the aspects still poorly understood, highlighting the divergent activity of ozone on the various biological districts. It will be clarified that such a dual effect does not depend only upon the final gas concentration, but also on the particular biological system where ozone acts. The real significance of ozone as adjuvant therapeutic treatment concerns severe chronic pathologies among which are cardiovascular diseases, chronic obstructive pulmonary diseases, multiple sclerosis, and the dry form of age-related macular degeneration. It is time for a full insertion of ozone therapy within pharmaceutical sciences, responding to all the requirements of quality, efficacy and safety, rather than as either an alternative or an esoteric approach.
Export Options
About this article
Cite this article as:
I. Zanardi, E. Borrelli, G. Valacchi, V. Travagli and V. Bocci , Ozone: A Multifaceted Molecule with Unexpected Therapeutic Activity, Current Medicinal Chemistry 2016; 23 (4) . https://dx.doi.org/10.2174/0929867323666151221150420
DOI https://dx.doi.org/10.2174/0929867323666151221150420 |
Print ISSN 0929-8673 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-533X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
How to Identify Subjects with Poly-Vascular Disease?
Current Vascular Pharmacology Assessment of Possible Drug Interactions in Patients with Psoriasis and Associated Comorbid Medical Conditions: An Observational Study
Reviews on Recent Clinical Trials Apo A-1 Mimetic Peptides as Atheroprotective Agents in Murine Models
Current Drug Targets Pharmacological Neuroprotection in Cardiac Surgery: Effectiveness of Pharmacologic-Preconditioning with Erythromycin
Current Vascular Pharmacology Editorial [Hot Topic:Stabilizing the Vulnerable Plaque: The Search for the Magic Bullet (Executive Editors: G. Pasterkamp and M. Daemen)]
Current Pharmaceutical Design Proteasome Inhibitors and Modulators of Angiogenesis in Multiple Myeloma
Current Medicinal Chemistry Low-Molecular Weight Heparins in Percutaneous Coronary Interventions: Current Concepts, Problems, and Perspectives
Current Pharmaceutical Design HGF as Angiogenic Factor and Therapeutic Approach
Current Signal Transduction Therapy Vitamin D status in coronary artery disease: association with IL-35 and TGF-β1 and disease severity
Endocrine, Metabolic & Immune Disorders - Drug Targets New Insights into Redox-Modulated Cell Signaling
Current Pharmaceutical Design Intranasal Fluorescent Nanocrystals for Longitudinal <i>In Vivo</i> Evaluation of Cerebral Microlesions
Pharmaceutical Nanotechnology T-Cells and B-Cells in Systemic Sclerosis
Current Rheumatology Reviews Regulation of Endothelial Nitric Oxide Synthase in Pathophysiological Conditions
Cardiovascular & Hematological Disorders-Drug Targets Physiology of Folic Acid in Health and Disease
Current Drug Metabolism Current Applications of Therapeutic Gases in Neonatal Intensive Care
Current Pediatric Reviews Persistent Pulmonary Hypertension of the Newborn: Physiology, Hemodynamic Assessment and Novel Therapies
Current Pediatric Reviews Role of the α7 Nicotinic Acetylcholine Receptor and RIC-3 in the Cholinergic Anti-inflammatory Pathway
Central Nervous System Agents in Medicinal Chemistry Detection of a γ-Carboxy-Glutamate as Novel Post-Translational Modification of Human Transthyretin
Protein & Peptide Letters Myocardial Infarction. Pathological Relevance and Relationship with Coronary Risk Factors
Current Pharmaceutical Design Thyroid Hormones and Cardiovascular System: From Bench to Bedside
Current Drug Therapy